(Total Views: 280)
Posted On: 06/13/2019 9:45:42 AM
Post# of 103530
$RHHBY News Article - Phase III PEMPHIX Study Showed That Genentech's Rituxan (Rituximab) is Superior to Standard of Care in Achieving Sustained Remission in Patients with Pemphigus Vulgaris https://marketwirenews.com/news-releases/phas...48350.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
